New antidiabetic medications have been introduced during the last decade, but their impact on health care cost is largely unknown. Prescription costs in diabetic patients in primary care in Germany were evaluated (1994-2004).
Rathmann, W., Haastert, B., Icks, A., & Giani, G. (2007). Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004. Diabetes Care, 30(4), 848–53. https://doi.org/10.2337/dc06-2000